跳至主要内容
临床试验/NCT00528658
NCT00528658已完成2 期

Cost-effectiveness Analysis of Oral Paracetamol and Ibuprofen for Treating Pain After Soft Tissue Limb Injuries: Double-blind, Randomised Controlled Trial

Chinese University of Hong Kong1 个研究点 分布在 1 个国家目标入组 782 人开始时间: 2005年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
782
试验地点
1
主要终点
analgesic efficacy both at rest and with movement

研究概览

简要总结

Background: Paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen are commonly used oral analgesics in emergency departments (ED) not only in Hong Kong but throughout the world. There are no large-scale (n>100), prospective, randomised studies comparing paracetamol with ibuprofen in the management of acute soft tissue injury.

As paracetamol is cheaper than most NSAIDs, may be as effective in the management of acute pain and possibly with fewer adverse effects, a large-scale, randomised, controlled trial is needed to answer questions of relative analgesic efficacy, safety and cost-effectiveness. Previous comparative studies on NSAIDS have been done in this unit and have suggested equivalence between two NSAIDs and paracetamol, but numbers were small and drug doses were modest.

Objective: To compare the efficacy, safety and cost between oral ibuprofen and paracetamol in pain control for acute soft tissue injuries in an ED setting

Design: Prospective, double-blind, randomised controlled trial with three arms: oral paracetamol with placebo; oral ibuprofen with placebo; paracetamol and ibuprofen in combination

Participants: 783 subjects having sustained isolated soft tissue limb injury without significant fracture presenting to the ED of Prince of Wales Hospital

Main outcome measures: Pain relief profiles of paracetamol, ibuprofen and the combination of both; adverse effect profiles of paracetamol, ibuprofen and the combination of both; overall cost effectiveness of paracetamol, ibuprofen and the combination of both from the perspective of the healthcare provider

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
16 Years 至 100 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients >16 years presenting to the ED with isolated soft tissue injury without significant fracture
  • between 9am to 5pm, Monday to Friday,

排除标准

  • History of :
  • peptic ulceration or hemorrhage
  • recent anticoagulation
  • pregnancy
  • adverse reaction to paracetamol or ibuprofen
  • renal or cardiac failure
  • hepatic problems
  • rectal bleeding
  • chronic NSAID consumption
  • chronic obstructive pulmonary disease
  • chronic pain syndromes
  • prior treatment with analgesia for the same injury
  • physical, visual or cognitive impairment making use of the visual analogue scale unreliable

研究组 & 干预措施

1

Experimental

干预措施: Paracetamol (Drug)

1

Experimental

干预措施: Ibuprofen placebo (Drug)

2

Experimental

干预措施: Ibuprofen (Drug)

2

Experimental

干预措施: Paracetamol Placebo (Drug)

3

Experimental

干预措施: Paracetamol (Drug)

3

Experimental

干预措施: Ibuprofen (Drug)

结局指标

主要结局

analgesic efficacy both at rest and with movement

时间窗: 72 hours

次要结局

  • presence, frequency and duration of adverse effects; cost-effectiveness analysis; patient satisfaction with analgesia(30 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Colin Graham

Professor

Chinese University of Hong Kong

研究点 (1)

Loading locations...

相似试验